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Background: The use of local infiltration analgesia in the setting of knee arthroplasty is well established. There are
no studies to date which have directly compared differences in infiltration techniques. The purpose of this study is
to establish if a difference in patient outcomes exists when the infiltrate is injected into the periarticular tissues or
directly into the joint.
Methods: One hundred and forty-two consecutive patients waitlisted for primary total knee arthroplasty were
enrolled after primary exclusion criteria were applied. These included the following: allergy to study drugs, inability
to receive spinal anaesthesia, and planned bilateral surgery. Patients were divided into two groups, a periarticular
infiltration group (group A) and an intraarticular infiltration group (group B). Secondary exclusion criteria of regular
opioid use, psychiatric illness, and serious medical comorbidity left a total of 47 patients in group A and 54 patients
in group B. Both groups received a combination of 30 mg ketorolac, 500 μg of adrenaline, and 300 mg of ropivacaine,
and normal saline. This was either injected into the periarticular tissues during surgery (group A) or intraarticularly after
closure of the wound (group B).
Primary outcome measures included opioid consumption during the first 24 h postoperatively and over the total
admission, and visual analogue scales (VAS) on postoperative day 1 and at discharge. Secondary measures included
Oxford Knee Score, knee flexion, length of stay, haemoglobin drop, and transfusion requirement.
Ethics approval was granted by the hospital review board. The trial is registered in the Australian New Zealand Clinical
Trials Registry, registration ACTRN12615000488505.
Results: No statistically significant differences in postoperative analgesic use were observed between the two groups.
However, there was a trend toward decreased postoperative patient-controlled analgesia use in the periarticular group
(mean 53.1 vs 68.3 mg morphine equivalents; p = 0.093), as well as a statistically significant reduction in postoperative
visual analogue pain scores. No statistically significant differences were observed for haemoglobin drop, range of
motion, or pre- to 6-week postoperative Oxford Score difference.
Conclusions: Our study is the first we are aware of to directly compare a periarticular to intraarticular injection
technique when using local infiltration analgesia for total knee arthroplasty. Our results show no clear statistically
significant benefit with either technique. The periarticular group showed a statistically significant reduction in
postoperative VAS pain scores alongside a trend in that group toward reduced overall opioid use.
Keywords: Local infiltration analgesia, Local anaesthetic, Total knee arthroplasty, Total knee replacement* Correspondence: mikeperret@gmail.com
1Department of Orthopaedics, Fremantle Hospital, Alma St, Fremantle, WA
6160, Australia
Full list of author information is available at the end of the article
© 2015 Perret et al. This is an Open Access art
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Perret et al. Journal of Orthopaedic Surgery and Research  (2015) 10:119 Page 2 of 7Background
Total knee arthroplasty for osteoarthritis is a common
procedure, with over 50,000 procedures performed each
year in Australia [1]. Demand for the operation is in-
creasing as the population continues to age and expand.
The procedure is associated with significant postopera-
tive pain, and interest has grown in local infiltration an-
algesia (LIA) which has gained popularity in part due
to the side effects of traditional systemic opioid-based
regimens.
Kerr and Kohan [2] developed a LIA technique in
which ropivacaine, ketorolac, and adrenaline are infiltrated
into the periarticular tissues at the time of surgery, and
also postoperatively via an intraarticular catheter. The effi-
cacy of LIA techniques in the setting of total knee arthro-
plasty has been supported by multiple studies in the
literature [3–7].
Several modifications to the technique described by
Kerr and Kohan have been published, including alter-
ations in the composition of infiltrated agents, their con-
centrations and volumes, the timing and location of
infiltration, and the use of intraarticular catheters for
postoperative infusion. In the interests of refining our LIA
technique, we undertook a literature review and found
that there were no studies which directly compared a peri-
articular to an intraarticular injection technique.
The purpose of our study was to investigate the differ-
ence in outcomes of two separate methods of adminis-
tering LIA, namely intraarticular and periarticular tissue
infiltration. Primary measures investigated were related
to analgesic efficacy, measured by postoperative opioid
consumption and visual analogue pain scores. Secondary
endpoints included an assessment of functional outcome
in terms of the Oxford Knee Score, length of stay (LOS),
range of motion (ROM), and postoperative haemoglobin
(Hb) drop as an indirect measure of blood loss.
Methods
Ethics approval was granted by the hospital research and
ethics committee.
We identified patients scheduled for primary total
knee arthroplasty for osteoarthritis. Patients were en-
rolled from a public hospital orthopaedic outpatient
clinic between April 2008 and January 2012, and were
allocated to either the periarticular infiltration group
(group A) or the intraarticular group (group B) depend-
ing on the date of their surgery. All patients gave their
informed consent to participate. Seventy-one patients
were identified in the first 18 months of the study period
and were assigned to group A. The following 71 patients
were allocated to group B, giving a total of 142 consecu-
tive patients. Trial exclusion criteria were allergy or in-
tolerance to study drugs, known inability to receive
spinal anaesthesia, and planned bilateral knee surgery.A retrospective review of medical records identified
patients with a history of at least once-daily opioid use,
concurrent active psychiatric illness (not including con-
trolled depression/anxiety), serious medical comorbidities
that might prolong hospital admission, and coagulation
disorders, and these patients were also excluded from our
analysis.
All surgery was performed under spinal anaesthesia by
a consultant surgeon and/or his fellow using the same
technique as described below:
A standard medial parapatellar approach was used. A
tourniquet was inflated at the start of the procedure and
deflated after skin closure. One gram of tranexamic acid
was given orally 1 h before surgery and 6 h after. Two
grams of intravenous cephazolin was given at induction.
Patients all received a PFC Sigma RP posterior stabi-
lised (Depuy, Warsaw, IN) prosthesis, which was cemen-
ted with Palacos with gentamycin cement (Heraeus
Kulzer, Hanau, Germany). The patella was resurfaced
on all patients.
A combination of 30 mg of ketorolac (1 mL), 500 μg
of adrenaline (5 mL of 1:10,000), and 300 mg of ropiva-
caine (40 mL of 0.75 %) was added to normal saline to
create a total volume of 150 mL. This was based on the
regime described by Kerr and Kohan [2].
In group A patients, the 150 mL was infiltrated after
implantation of the prosthesis, prior to insertion of the
polyethylene liner. Of this, 50 mL was infiltrated into
the posterior capsule and intercondylar area; 50 mL was
infiltrated into the anterior capsule, the collateral liga-
ments, and along the femur and tibia; and the remaining
50 mL was infiltrated into subcutaneous tissue following
closure of the capsule. Group B patients had all of the
150 mL injected intraarticularly after closure of the
wound. No drains were inserted.
Postoperatively, all patients received paracetamol 1 g
6-hourly and the use of a patient-controlled analgesia
(PCA) device with fentanyl (10 μg bolus, 6 min lockout)
or morphine (1 mg bolus, 6 min lockout). The PCA was
discontinued after clinical review by the anaesthetist,
usually 24 h postoperatively. Rescue oral analgesia in the
form of oxycodone IR (immediate release) or tramadol
was administered as required throughout the course of
the admission. All patients received 40 mg enoxaparin
daily for deep vein thrombosis prophylaxis commencing
the following morning.
Mobilisation was attempted on the first postoperative
day under the supervision of a physiotherapist, and a
standardised rehabilitation programme was delivered to
the patients. This involved twice-daily sessions with the
physiotherapist until the patients were able to independ-
ently mobilise with a gait aid, perform independent
transfers, and undertake basic activities of daily living.
Patients were discharged home once these criteria
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with oral analgesia, and there was no evidence of sur-
gical complication.
Primary outcomes
The primary outcome measures were opioid consump-
tion during the first 24 h, total opioid consumption over
admission, and visual analogue scales (VAS) on postop-
erative day 1 and at discharge. Opioid doses were con-
verted into morphine equivalents [8].
Secondary outcomes
Oxford Knee Scores were calculated preoperatively and
6 weeks postoperatively. Knee flexion was measured pre-
operatively, at discharge, and 6 weeks postoperatively.
Length of stay was noted. Preoperative and postoperative
haemoglobin measurements on postoperative day 1 were
recorded as a marker for operative blood loss, as was
any requirement for blood transfusion. Requirement for
transfusion was determined by our local hospital guide-
lines of symptomatic anaemia (associated with increased
oxygen requirement or cardiorespiratory decompensa-
tion) or active bleeding.
Statistics
Differences between groups A and B for PCA usage,
total opioid analgesia, Oxford Score, range of motion,
haemoglobin drop, VAS at day 1 and discharge, and





Total opioid analgesia (24 h) 58.7 (45.8)
Total opioid analgesia (admission) 118.5 (109.5)
Oxford (pre) 41.1 (5.5)
Oxford (6 weeks post) 20.9 (6.6)
Oxford (difference) −19.9 (7.9)
ROM (pre) 111.1 (17.1)
ROM (6 weeks post) 110.8 (12.8)
ROM (difference) −0.30 (15.9)
Haemoglobin (difference) 26.4 (8.6)
VAS day 1 3.83 (2.0)
VAS discharge 2.47 (1.6)
VAS discharge without outliers 2.24 (1.2)
LOS 4.30 (2.1)
LOS without outliers 3.86 (1.2)
*p value of <0.05variance. Boxplots of each variable were also created to
detect possible outliers.
PCA usage, total opioid analgesia (24 h), and total opi-
oid analgesia (over admission) were also assessed in a
multiple regression model to see if there was a difference
between groups A and B after adjusting for age, Oxford
Score (pre- and postoperatively), and ROM (pre- and
postoperatively). Square root transformations were used
for PCA usage and both measures of total opioid anal-
gesia to correct for violations of the constant variance
assumption for regression.
Results
A total of 142 patients were enrolled into our study. Of
these, 41 were secondarily excluded, most commonly for
history of regular opioid use. Where incomplete data
were identified, the number of patients excluded is
shown in Table 1.
The number of patients in group A was 47 and group




Mean values for the primary endpoints of PCA use, total
opioid analgesia (24 h), and total opioid analgesia (ad-
mission) were lower in group A than in group B, though
these differences were not statistically significant (Fig. 1).
Plots of PCA use over 24 h postoperatively, total opi-
oid analgesia use over 24 h postoperatively, and totalGroup B p value
n Mean (sd) n
47 66.2 (9.4) 54 0.1717
47 68.3 (49.3) 54 0.0934
47 72.4 (50.7) 54 0.1667
47 125.7 (74.9) 54 0.7060
47 40.8 (5.9) 51 0.8053
42 24.2 (5.4) 41 0.0143*
42 −16.8 (8.0) 41 0.0869
47 112.1 (14.6) 54 0.7398
47 109.7 (10.2) 54 0.6309
47 −2.48 (15.5) 54 0.4885
45 24.2 (8.4) 51 0.2130
47 4.63 (1.8) 54 0.0391*
47 2.87 (1.5) 54 0.2014
47 2.87 (1.5) 54 0.0253*
47 3.44 (0.7) 54 0.0104*
47 3.44 (0.7) 54 0.0386*
Fig. 1 Opioid usage in the first 24 h postoperatively and over total admission, comparing infiltrate (group A) vs injection (group B)
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liers. When these were removed, the difference between
groups A and B was still not significant (p values =
0.1739, 0.2950, and 0.1980, respectively).
VAS
VAS scores in group A were significantly lower than
those in group B at postoperative day 1 (3.83 vs 4.63; p
value = 0.039). VAS scores in group A were also lower
than those in group B at discharge, though this differ-
ence was not significant (Fig. 2). Boxplots for VAS at
discharge indicated possible outliers, and the differenceFig. 2 VAS at postoperative day 1 and at discharge, comparing infiltrate (gbetween group A and group B reached statistical signifi-




The LOS data demonstrated a significantly higher LOS
in group A patients (4.30 vs 3.44 days; p value = 0.0104).
The boxplots indicated three possible outliers: two with
LOS of 9 days and one with 14 days. These prolonged
admissions were a result of medical complications.
When these outliers are removed, the difference in LOSroup A) vs injection (group B)
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0.0386).
Oxford Scores
The groups were similar in terms of preoperative Oxford
Scores; however, the 6-week postoperative Oxford
Scores were different, with group B having a significantly
better (higher) Oxford Score than group A (24.2 vs 20.9;
p value = 0.0143). This statistically significant effect dis-
appeared when the scores were compared to preopera-
tive scores (Fig. 3).
Knee range of motion
No statistically significant difference was demonstrated
between groups.
Haemoglobin drop
There was minimal difference between the groups when
postoperative haemoglobin drop was examined and
there was no statistical significance. There were a total
of four transfusions recorded (two in each group).
Multiple regression analysis
PCA, total opioid analgesia (24 h), and total opioid anal-
gesia (admission) were assessed in a multiple regression
model to examine if there was a difference between
groups A and B after adjusting for age, Oxford Score
(pre- and postoperative), and ROM (pre- and postopera-
tive) (Table 2).
The initial analysis indicated a problem with the vari-
ance of the residuals, so a square root transformation
was used for the response variable. The results indicatedFig. 3 Oxford Knee Scores preoperatively and at 6 weeks postoperatively, cthat after adjusting for these variables, there was still no
difference between groups A and B as this variable indi-
cating treatment group was not significant. The models
were initially fitted with group, age, preoperative Oxford
Score, postoperative Oxford Score, and pre- and postop-
erative ROM, and subsequently the non-significant vari-
ables were removed.
Discussion
The role of LIA in the setting of total knee arthroplasty
has been established in the literature. The goal of our
study was to determine any difference in primary and
secondary outcome measures when periarticular infiltra-
tion was compared to intraarticular injection at the time
of surgery. To our knowledge, there have been no pub-
lished studies examining this.
The techniques for LIA and in particular the target tis-
sues vary in the literature. It is still unclear which tissues
are responsible for generating pain in the setting of total
knee arthroplasty. Periarticular infiltration techniques
target the joint capsule, deep tissues surrounding the
collateral ligaments, and the subcutaneous tissues and
wound edges [2]. Anderson et al. [3] found that ropiva-
caine infiltrated into the subcutaneous tissues intraoper-
atively was a key component in postoperative pain
control. The study also concluded that ropivacaine bo-
luses administered via a catheter placed in the subcuta-
neous tissues 24 h postoperatively were ineffective and
of no benefit in terms of patient analgesia.
Several studies have examined the efficacy of intraarticu-
lar infiltration, both intraoperatively and postoperatively.
Badner et al. [6] found that intraarticular injections ofomparing infiltrate (group A) vs injection (group B)
Table 2 Multiple regression results—significant variables only
Response variable Independent variables Coefficient p value
Sqrt (PCA) Age −0.089 0.0104
Oxford (post) 0.145 0.0057
Sqrt (total opioid analgesia [24 h]) Age −0.107 0.0038
Oxford (post) 0.163 0.0080
Sqrt (total opioid analgesia [admission]) Age −0.165 0.0001
Oxford (pre) 0.177 0.0092
Oxford (post) 0.160 0.0096
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postoperative need for opiates in total knee arthroplasty.
These results were not supported by a subsequent larger
study by Ritter et al. [7]. A study of 60 patients undergoing
total knee arthroplasty published in 2004 [5] found that a
bupivacaine bolus injected intraarticularly at capsule clos-
ure was associated with reduced opioid consumption,
though this result was not statistically significant. None of
these studies found a statistically significant reduction in
measured pain scores.
The benefit of intraarticular catheters to provide sup-
plementary dosages of local anaesthetic in the postoper-
ative period is unproven. In addition to the lack of
evidence surrounding the benefit of ongoing boluses,
intraarticular catheter placement is less desirable given
the potential for infection. Essving et al. [4] cultured
drain tips from 48 patients at 24 h post total knee
arthroplasty, with three resultant positive coagulase-
negative Staphylococcus cultures. No clinically significant
infections developed in these patients.
Our results did not show any statistically significant
difference between groups in postoperative opioid require-
ments. The periarticular group showed trends toward re-
duced PCA usage (53.1 vs 68.3 mg morphine equivalent;
p = 0.093) and reduced total opioid analgesia requirement
within 24 h postoperatively (58.7 vs 72.4 mg; p = 0.167).
The total opioid analgesic requirement over admission
was similar between groups (118.5 mg in group A vs
125.7 mg in group B; p = 0.706), though when considered
alongside LOS data, this analgesia was spread over a lon-
ger length of stay in the periarticular group.
It has been observed in the literature [3–7] that peri-
articular infiltration is effective in reducing opioid con-
sumption postoperatively. This would suggest that the
tissues responsible for generating pain in the setting of
total knee arthroplasty may be better targeted by a peri-
articular technique. The authors of a systematic review
of the literature in 2012 [9] advocated delivery by sys-
tematic infiltration of all exposed tissues, including the
posterior capsule. In our experience, there is a small
amount of crossover in techniques, as during periarticu-
lar infiltration, there is inevitably a small amount ofsolution that remains within the joint, and in intraarticu-
lar injection, solution may escape into the periarticular
tissues.
Interestingly, multiple regression analysis showed that
as age increased, the amount of PCA used, total opioid
analgesia during the first 24 h, and total opioid analgesia
over the course of the admission tended to decrease.
The reason for this age-related reduction in analgesic re-
quirement is unclear; it may be related to reduced me-
tabolism of opioids in the elderly or possibly reduced
rates of pain reporting in this population.
There was a statistically significant decrease in the
VAS scores of patients in the periarticular group when
compared to the intraarticular group 24 h postopera-
tively. This occurred alongside a trend toward reduced
early opioid requirements in this group—these patients
experienced less pain whilst possibly requiring less opi-
oids. Although the observed reduction in PCA use (53.1
vs 68.3 mg morphine equivalents; p = 0.093) fails to
reach statistical significance, in combination with re-
duced VAS scores at 24 h, it lends support to a possible
advantage in the periarticular technique. It is also noted
that once outliers from the periarticular group are re-
moved, there is a statistically significant decreased VAS
on discharge. This is unexpected as the duration of ac-
tion of LIA agents is far less than our average length of
stay (3.9 days).
Another possible explanation for the higher VAS scores
observed in the intraarticular injection group relates to
the large volume of fluid and subsequent swelling of the
knee joint with intraarticular injection. A proportion of
this fluid will inevitably escape into the surrounding tis-
sues or be quickly reabsorbed. A similar volume effect
may occur to a lesser extent in the periarticular group as
blood collects in the joint postoperatively, though the
overall volumes are likely to be larger in the periarticular
group.
Our measured length of stay data is contradictory to
the reduced VAS scores at 24 h and at discharge ob-
served in the periarticular infiltration group, in that the
intraarticular group showed a statistically significant
shorter length of stay (3.86 vs 3.44 days; p = 0.0386, with
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of discharge in the periarticular group may be partly ex-
plained by the fact that these patients had slightly longer
to recover from their surgery.
Oxford Knee Scores at 6 weeks postoperatively were
observed to be higher in the intraarticular group (24.2 vs
20.9; p = 0.0143), though this benefit disappeared once
preoperative scores were considered and a difference be-
tween pre- and postoperative scores was calculated.
There was no significant difference in the mean haemo-
globin drop between the groups. It has been postulated
that adrenaline may reduce postoperative bleeding by a
vasoconstrictive and tamponade effect. We recognise the
shortfalls in measuring haemoglobin as a surrogate marker
of local bleeding, and could not account for confound-
ing factors arising from patient comorbidities and sur-
gical technique. Our result is however consistent with
the literature, as documented in a systematic review by
Gibbs et al. [9].
Other limitations of our study included a lack of ran-
domisation, potential inaccuracy in the standardisation
of morphine equivalents, and use of differing analgesic
regimes between patients. It would have been beneficial
to increase the frequency of VAS measurements and
opioid usage especially early in the postoperative period
to further stratify any differences.
Conclusion
We are not aware of any other study that compares tar-
geting different tissues using local infiltration analgesia
during total knee arthroplasty. Our results demonstrated
no statistically significant difference in our primary end-
point of opioid usage between periarticular and intraarticu-
lar groups. Periarticular infiltration was associated with
reduced VAS scores at 24 h postoperatively and at dis-
charge (with outliers removed), and a slightly longer length
of stay.
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